Activation of microglia by aggregated beta-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-gamma and IL-4 render them protective

Mol Cell Neurosci. 2005 Jul;29(3):381-93. doi: 10.1016/j.mcn.2005.03.005.

Abstract

'Protective autoimmunity' refers to a well-controlled anti-self response that helps the body resist neurodegeneration. The response is mediated by autoimmune T cells, which produce cytokines and growth factors. Using an in vitro assay of hippocampal slices, we show that the cytokines interferon-gamma and (especially) interleukin-4, characteristic of pro-inflammatory and anti-inflammatory T cells, respectively, can make microglia neuroprotective. Aggregated beta-amyloid, like bacterial cell wall-derived lipopolysaccharide, rendered the microglia cytotoxic. Cytotoxicity was correlated with a signal transduction pathway that down-regulates expression of class-II major histocompatibility proteins (MHC-II) through the MHC-II-transactivator and the invariant chain. Protection by interleukin-4 was attributed to down-regulation of tumor necrosis factor-alpha and up-regulation of insulin-like growth factor I. These findings suggest that beneficial or harmful expression of the local immune response in the damaged CNS depends on how microglia interpret the threat, and that a well-regulated T-cell-mediated response enables microglia to alleviate rather than exacerbate stressful situations in the CNS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid beta-Peptides / antagonists & inhibitors
  • Amyloid beta-Peptides / immunology
  • Amyloid beta-Peptides / pharmacology
  • Animals
  • Animals, Newborn
  • Autoimmunity / drug effects
  • Autoimmunity / immunology
  • Cell Line
  • Cells, Cultured
  • Down-Regulation / drug effects
  • Down-Regulation / immunology
  • Encephalitis / immunology*
  • Encephalitis / physiopathology
  • Encephalitis / therapy
  • Gliosis / immunology*
  • Gliosis / physiopathology
  • Gliosis / therapy
  • Hippocampus / drug effects
  • Hippocampus / immunology
  • Hippocampus / physiopathology
  • Histocompatibility Antigens Class II / drug effects
  • Histocompatibility Antigens Class II / immunology*
  • Insulin-Like Growth Factor I / drug effects
  • Insulin-Like Growth Factor I / immunology
  • Interferon-gamma / immunology*
  • Interferon-gamma / pharmacology
  • Interleukin-4 / immunology*
  • Interleukin-4 / pharmacology
  • Lipopolysaccharides / antagonists & inhibitors
  • Lipopolysaccharides / immunology
  • Lipopolysaccharides / pharmacology
  • Lymphocyte Activation / drug effects
  • Lymphocyte Activation / immunology
  • Microglia / drug effects
  • Microglia / immunology*
  • Neurodegenerative Diseases / immunology
  • Neurodegenerative Diseases / physiopathology
  • Neurodegenerative Diseases / therapy
  • Organ Culture Techniques
  • Rats
  • Rats, Sprague-Dawley
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology
  • Transcriptional Activation / drug effects
  • Transcriptional Activation / physiology
  • Tumor Necrosis Factor-alpha / drug effects
  • Tumor Necrosis Factor-alpha / immunology

Substances

  • Amyloid beta-Peptides
  • Histocompatibility Antigens Class II
  • Lipopolysaccharides
  • Tumor Necrosis Factor-alpha
  • Interleukin-4
  • Insulin-Like Growth Factor I
  • Interferon-gamma